Microparticulated Polygonatum sibiricum polysaccharide shows potent vaccine adjuvant effect

Kai Shen,Jinlong Zhang,Zhenghao Zhao,Hao Ma,Yudong Wang,Wanru Zheng,Jinghan Xu,Yao Li,Busen Wang,Zhe Zhang,Shipo Wu,Lihua Hou,Wei Chen
DOI: https://doi.org/10.1016/j.ijpharm.2024.123802
IF: 6.51
2024-01-13
International Journal of Pharmaceutics
Abstract:Adjuvants are necessary for protein vaccines and have been used for nearly 100 years. However, developing safe and effective adjuvants is still urgently needed. Polysaccharides isolated from traditional Chinese medicine are considered novel vaccine adjuvant sources. This study aimed to investigate the adjuvant activity and immune-enhancing mechanisms of the microparticulated Polygonatum sibiricum polysaccharide (MP-PSP) modified by calcium carbonate. PSP demonstrated adjuvant activity, and MP-PSP further showed a higher humoral response compared to PSP. Subsequently, MP-PSP was elucidated to improving the immunity by slowing the rate of antigen release and activating dendritic cells along with interleukin-6 secretion through toll-like receptor 4 signaling, followed by T follicular helper cell and B cell interactions. Moreover, MP-PSP had a good safety profile in vaccinated mice. Thus, MP-PSP may be a promising vaccine adjuvant and warrants further investigation.
pharmacology & pharmacy
What problem does this paper attempt to address?